MYXREDLIN 1 UNIT
INSULIN (HUMAN) : 1 UNIT · DIN 02529602 · BAXTER CORPORATION
Health Canada status: MARKETED
What is MYXREDLIN?
MYXREDLIN 1 UNIT contains INSULIN (HUMAN) : 1 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02529602, held by BAXTER CORPORATION, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 28-Jul-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02529602 |
|---|---|
| Brand name | MYXREDLIN |
| Generic / active ingredient | INSULIN (HUMAN) : 1 UNIT |
| Manufacturer | BAXTER CORPORATION |
| Strength | 1 UNIT |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | A10AB01 INSULIN (HUMAN) |
| AHFS class | 68:20.08.08 |
| Biosimilar | Yes |
| Health Canada status | MARKETED |
| Status date | 28-Jul-2023 |
| Original market date | 2023-07-28 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A10AB01 INSULIN (HUMAN). 4 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| HUMULIN R (KWIKPEN) | 100 UNIT | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02415089 |
| HUMULIN R CARTRIDGE | 100 UNIT | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 01959220 |
| NOVOLIN GE TORONTO | 100 UNIT | SOLUTION | NOVO NORDISK CANADA INC | MARKETED | DIN 02024233 |
| HUMULIN R | 100 UNIT | SOLUTION | ELI LILLY CANADA INC | CANCELLED POST MARKET | DIN 00586714 |
| ILETIN INSULIN REGULAR 100UNIT/ML | 100 UNIT | LIQUID | ELI LILLY AND COMPANY LIMITED | CANCELLED POST MARKET | DIN 00446564 |
| NOVOLIN GE TORONTO PENFILL | 100 UNIT | SOLUTION | NOVO NORDISK CANADA INC | CANCELLED POST MARKET | DIN 02024284 |
| NOVOLINSET GE TORONTO INJ LIQ 100U/ML | 100 UNIT | LIQUID | NOVO NORDISK A/S | CANCELLED POST MARKET | DIN 02025256 |
| VELOSULIN HUMAN INJ LIQ 100U/ML | 100 UNIT | LIQUID | NOVO NORDISK A/S | CANCELLED POST MARKET | DIN 01986805 |
Who else supplies INSULIN (HUMAN) worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. INSULIN (HUMAN) appears in 441 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.